In this case the license was Noncommercial no-derivatives. Wiley, the article's publisher, were obeying the license. Elsevier were not; why was a third party selling (commercially) an article they had no license to sell?
(It's certainly possible Elsevier overstepped its rights… but no one making that allegation has yet supplied enough evidence to be sure that's what happened.)